Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
2. Merck & Co.
Merck vaccine hopeful to battle Pfizer's Prevnar in phase 3
Wednesday, April 18, 2018
Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.
Merck posts $6.5B in 2017 vaccine sales, helped by Gardasil
Tuesday, February 6, 2018
Despite new challenges in shingles, Merck's vaccine business kept churning in 2017, generating sales of $6.5 billion—an increase of 4.8%.
Merck's Gardasil posts big Q1 beat
Tuesday, May 2, 2017
Merck’s vaccines powered ahead to start the year, turning in a 21% surge in sales and helping the drug giant offset other areas of weakness on the way to slight growth overall.
SutroVax reels in $64M to take on $7B vaccine market
Tuesday, March 21, 2017
Armed with $64 million in new venture funding, San Francisco’s SutroVax is setting out to challenge the world’s biggest target in vaccines, Pfizer’s superstar pneumococcal shot Prevnar 13.
Gardasil faces 'negative impact' of HPV regimen change
Tuesday, February 7, 2017
Gardasil could see some trouble in the U.S. this year, Merck is advising.
Gardasil leads the charge as Merck vaccines soar in Q3
Wednesday, October 26, 2016
With some key meds falling short of expectations in the third quarter, Merck’s vaccines turned in impressive sales to help carry the drug giant to overall growth.
Clinton's pneumonia gives Merck, Pfizer vaccines new fame
Wednesday, September 14, 2016
Hillary Clinton may not be Big Pharma's best friend these days, but her pneumonia diagnosis is lending a hand to vaccines from Merck & Co. and Pfizer.